212.17 USD
▲-8.70+0.54%
2026-08-03
市值
$10.92B
市盈率
—
EPS
-3.74
股息率
—
52 周区间
96.09 – 260.19
成交量
473.47K
Beta
0.72
目标价
282.51
52W 低 96.0952W 高 260.19
价格走势
公司简介
Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate receptor antagonist, sigma-1 receptor agonist, aminoketone, and CYP2D6 inhibitor indicated for the treatment of major depressive disorder in adults; Sunosi (solriamfetol), a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 ago...